Compared to Estimates, OPKO Health (OPK) Q4 Earnings: A Look at Key Metrics

Core Insights - OPKO Health reported a revenue of $148.5 million for the quarter ended December 2025, reflecting a decline of 19.1% year-over-year, but exceeded the Zacks Consensus Estimate by 7.56% [1] - The company's EPS was -$0.04, a decrease from $0.01 in the same quarter last year, but surpassed the consensus estimate of -$0.07 by 39.39% [1] Revenue Breakdown - Revenue from services was $71.1 million, slightly below the average estimate of $72.37 million, marking a year-over-year decline of 31% [4] - Revenue from the transfer of intellectual property and other sources was $33.7 million, exceeding the average estimate of $24.39 million, with a year-over-year decrease of 21.8% [4] - Revenue from products reached $43.7 million, surpassing the estimated $41.31 million, and showed a year-over-year increase of 16.8% [4] Stock Performance - OPKO Health's shares have returned -7.8% over the past month, contrasting with a +0.6% change in the Zacks S&P 500 composite [3] - The stock currently holds a Zacks Rank 3 (Hold), suggesting it may perform in line with the broader market in the near term [3]